Medicare & AI: How Technology Is Changing What’s Covered

The Rise of AI in Healthcare Coverage

For decades, Medicare coverage decisions were made through relatively straightforward processes: physicians submitted claims, administrators reviewed them, and payments were approved or denied based on established criteria. Today, artificial intelligence is inserting itself into nearly every step of that journey — from the initial diagnosis to the final reimbursement.

The Centers for Medicare & Medicaid Services (CMS) has been cautiously but consistently integrating AI-driven tools to improve efficiency, reduce fraud, and expand access to emerging treatments. The implications for beneficiaries are profound — and the changes are accelerating.

AI-Powered Prior Authorization: Faster Approvals or a New Barrier?

One of the most consequential areas where AI is changing Medicare involves prior authorization — the process by which insurers decide whether a treatment or medication is medically necessary before approving coverage. Traditionally, this process could take days or even weeks, leaving patients in limbo while awaiting critical care.

AI algorithms can now analyze a patient’s complete medical history, compare it against thousands of clinical guidelines, and render a recommendation in minutes. For routine procedures, this can dramatically speed up approvals and reduce administrative burden on physicians.

However, consumer advocates have raised concerns. When AI flags an unusual but clinically valid treatment as non-standard, automatic denials can follow. Congress and CMS have responded by requiring that AI-generated denials be reviewed by licensed clinicians — a critical safeguard that beneficiaries should know about when appealing coverage decisions.

Predictive Analytics and Coverage Expansion

AI isn’t only being used to gatekeep — it’s also opening doors to coverage that previously didn’t exist. Predictive analytics tools can now identify patients at high risk for conditions like heart failure, diabetes complications, or readmission after surgery. By flagging these individuals early, Medicare programs can authorize preventive interventions before expensive crises occur.

This has led to expanded coverage in several categories:

• Remote patient monitoring: Wearable devices and continuous glucose monitors that feed data into AI platforms are now reimbursable under certain Medicare plans.
• Behavioral health services: AI-driven screening tools have helped identify mental health needs that were historically underdiagnosed in older adults, supporting coverage expansions in telehealth therapy.
• Precision medicine: Genetic testing and AI-guided oncology treatments are gaining Medicare coverage as clinical evidence accumulates and algorithms improve.

The promise of AI in Medicare isn’t just efficiency — it’s the possibility of coverage decisions that are more accurate, more equitable, and more attuned to each individual’s health journey.

— Health Technology Policy Expert

Prescription Drug Coverage in the Age of AI

The intersection of artificial intelligence and Medicare Prescription Drug Plans (Part D) is particularly noteworthy. AI tools are now being deployed to:

• Identify drug-drug interactions in real time at the point of dispensing, potentially preventing dangerous combinations before they harm patients.
• Optimize formulary design by analyzing population-level prescribing patterns to ensure the most commonly needed medications are accessible at lower cost tiers.
• Detect prescription fraud — a significant drain on Medicare resources — by spotting anomalies that human auditors would likely miss.
• Personalize step therapy protocols, which determine the sequence in which medications should be tried, based on a patient’s specific clinical profile.

For beneficiaries, this means Part D plan recommendations are increasingly being shaped by algorithms that assess vast datasets. Understanding how your plan’s formulary is structured — and knowing your rights to appeal coverage decisions — is more important than ever.

Medicare Supplement Plans: What AI Means for Medigap

While original Medicare and Medicare Advantage are the most discussed contexts for AI integration, holders of Medicare Supplemental Plans (Medigap) are not unaffected. Medigap policies cover costs that original Medicare doesn’t — like copayments, coinsurance, and deductibles — and insurers are using AI to:

• Assess risk more precisely during the underwriting process (in states where medical underwriting is permitted).
• Streamline claims processing, reducing delays for out-of-pocket reimbursements.
• Identify high-utilization patterns that may indicate a need for care coordination interventions.

Importantly, AI is also being used to help beneficiaries choose the right Medigap plan. Digital plan comparison tools powered by machine learning can now model expected out-of-pocket costs based on a beneficiary’s existing conditions and projected healthcare use — a major improvement over manual comparisons.

The Regulatory Landscape: What Protections Exist?

As AI takes on a greater role in coverage decisions, regulators have moved to establish guardrails. CMS issued guidance in 2024 requiring Medicare Advantage plans to ensure that AI tools used in utilization management must be consistent with coverage criteria under original Medicare — a significant protection against algorithmic over-restriction.

Key protections beneficiaries should know:

• Right to appeal: Any coverage denial — whether issued by a human or an AI system — can be appealed. AI-generated denials are not inherently more final than human ones.
• Clinician review requirement: Adverse coverage decisions must be reviewed by a qualified healthcare professional, not solely by an algorithm.
• Transparency: Insurers are increasingly required to disclose when AI is involved in coverage determinations, giving beneficiaries more context for their decisions.